immatics biotechnologies Company
Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.
Investors
Technology:
CAR-T, Cell-based gene therapy
Industry:
Public
Headquarters:
Tübingen, Baden-Wurttemberg, Germany
Founded Date:
2000-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
31
Total Funding:
556233156
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-10-10
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership